Manufacturer
Shilpa Medicare
Pharmaceutical manufacturer based in India
Indian manufacturerIndia
- Products listed
- 4
- Molecules
- 2
- Therapy areas
- 1
Shilpa Medicare is a pharmaceutical manufacturer based in India. MedsAcross lists 4 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- India
- Indian manufacturer
- Yes
- Also listed as
- Shilpa Medicare Limited
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Shilpa Medicare products through licensed channels, with the documents your regulator needs.
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bortezomib 3.5 mg/1.4 mL injectionIntravenous, subcutaneous Cold chainGeneric name | Bortezomib | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Pemetrexed disodium hemipentahydrate 100 mg/10 mL injectionIntravenousGeneric name | Pemetrexed disodium hemipentahydrate | US FDA | Available on request |
| Pemetrexed disodium hemipentahydrate 1000 mg/100 mL injectionIntravenousGeneric name | Pemetrexed disodium hemipentahydrate | US FDA | Available on request |
| Pemetrexed disodium hemipentahydrate 500 mg/50 mL injectionIntravenousGeneric name | Pemetrexed disodium hemipentahydrate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Shilpa Medicare
Send a request for any of these products. We confirm the licensed source, documents and lead time.